Bax is a vital homologue of Bcl-2, an enhancer of apoptosis, and can be used as an independent parameter for predicting the clinical prognosis of individuals with bladder cancer (Golestani Eimani et al., 2014; Liu et al., 2016). Here, BCL2 is linked to urinary bladder cancer.